United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
529.17
+51.01 (10.67%)
At close: Mar 9, 2026, 4:00 PM EDT
533.00
+3.83 (0.72%)
After-hours: Mar 9, 2026, 7:59 PM EDT
United Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 23,192 | 20,979 | 15,752 | 10,333 | 12,674 | 9,731 | |
| Market Cap Growth | 41.41% | 33.18% | 52.44% | -18.47% | 30.24% | 44.26% | |
| Enterprise Value | 18,533 | 16,644 | 11,546 | 6,197 | 9,415 | 7,022 | |
| Last Close Price | 529.17 | 487.25 | 352.84 | 219.89 | 278.09 | 216.08 | |
| PE Ratio | 18.99 | 15.72 | 13.18 | 10.49 | 17.43 | 20.45 | |
| Forward PE | 18.77 | 17.14 | 12.17 | 9.93 | 13.57 | 13.45 | |
| PS Ratio | 7.29 | 6.59 | 5.48 | 4.44 | 6.55 | 5.77 | |
| PB Ratio | 3.25 | 2.96 | 2.44 | 1.73 | 2.64 | 2.46 | |
| P/TBV Ratio | 3.32 | 3.01 | 2.49 | 1.76 | 2.67 | 2.49 | |
| P/FCF Ratio | 22.29 | 20.16 | 14.58 | 13.82 | 19.10 | 20.38 | |
| P/OCF Ratio | 14.86 | 13.44 | 11.87 | 10.57 | 15.79 | 16.27 | |
| PEG Ratio | 2.07 | 4.43 | 1.02 | 13.47 | 1.03 | 0.72 | |
| EV/Sales Ratio | 5.82 | 5.23 | 4.01 | 2.66 | 4.86 | 4.17 | |
| EV/EBITDA Ratio | 11.58 | 10.40 | 7.60 | 5.01 | 9.05 | 9.53 | |
| EV/EBIT Ratio | 12.23 | 10.99 | 7.98 | 5.24 | 9.52 | 10.22 | |
| EV/FCF Ratio | 17.81 | 15.99 | 10.69 | 8.29 | 14.19 | 14.71 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.05 | 0.12 | 0.17 | 0.20 | |
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.20 | 0.57 | 0.77 | 1.09 | |
| Debt / FCF Ratio | 0.04 | 0.04 | 0.29 | 0.94 | 1.21 | 1.68 | |
| Net Debt / Equity Ratio | -0.66 | -0.66 | -0.69 | -0.70 | -0.70 | -0.70 | |
| Net Debt / EBITDA Ratio | -2.91 | -2.91 | -2.92 | -3.40 | -3.22 | -3.77 | |
| Net Debt / FCF Ratio | -4.48 | -4.48 | -4.10 | -5.62 | -5.05 | -5.82 | |
| Asset Turnover | 0.42 | 0.42 | 0.40 | 0.35 | 0.35 | 0.35 | |
| Inventory Turnover | 2.26 | 2.26 | 2.30 | 2.41 | 1.55 | 1.36 | |
| Quick Ratio | 5.83 | 5.83 | 4.81 | 4.10 | 9.12 | 6.97 | |
| Current Ratio | 6.61 | 6.61 | 5.25 | 4.41 | 9.85 | 7.61 | |
| Return on Equity (ROE) | 19.71% | 19.71% | 19.23% | 18.27% | 16.61% | 12.94% | |
| Return on Assets (ROA) | 12.43% | 12.43% | 12.44% | 11.19% | 11.03% | 8.78% | |
| Return on Invested Capital (ROIC) | 29.23% | 30.64% | 31.29% | 28.34% | 27.09% | 21.21% | |
| Return on Capital Employed (ROCE) | 20.70% | 20.70% | 21.80% | 18.60% | 17.30% | 14.10% | |
| Earnings Yield | 5.75% | 6.36% | 7.59% | 9.53% | 5.74% | 4.89% | |
| FCF Yield | 4.49% | 4.96% | 6.86% | 7.23% | 5.24% | 4.91% | |
| Buyback Yield / Dilution | 1.24% | 1.24% | 2.41% | -2.47% | -2.54% | -6.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.